Equity Profile

ICLR

ICON Public Limited Company

Health CareLife Sciences Tools & Services$12.8B

May28Thu

Pre-Earnings Brief

UpcomingQ1-2026After Close5:00 PM EDT

Company Snapshot

ICON Public Limited Company (ICLR) operates in the health care sector, specifically in life sciences tools and services. The company plays a crucial role in supporting pharmaceutical and biotechnology companies with clinical development and commercialization services, which are essential for bringing new drugs to market.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance this quarter.

$2.43

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In the last quarter, ICON reported an EPS of $2.52, slightly above expectations. The stock reacted positively, gaining 4.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings this quarter, with a consensus EPS of $2.43 and revenue of $2.0B. The company has a strong track record of beating earnings estimates.

Bull Case

If ICON exceeds the EPS estimate, it could signal strong demand for its services, leading to further stock appreciation. The company has consistently beaten EPS estimates in recent quarters.

Bear Case

If ICON misses its EPS target, it may raise concerns about its growth prospects and market conditions, potentially leading to a decline in stock price.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of the company's profitability and performance this quarter.

Revenue

$2.0B

Revenue figures provide insight into the company's sales performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $2.43?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What insights will management provide on revenue growth and market demand?

Understanding revenue drivers will be crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate ICON's ability to leverage its recent operational efficiencies, which could lead to better-than-expected earnings.

Supporting Evidence

ICON has consistently beaten EPS estimates, suggesting a trend of strong performance.

The options market is pricing a modest move, indicating that many investors may not be anticipating a significant earnings surprise.

Key Risk

If ICON's revenue growth exceeds $2.1B, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether ICON can maintain its growth amid industry challenges.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.29 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a relatively modest move around the earnings report, suggesting uncertainty about the outcome.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests the stock could rise by around 1.22%, confirming strong demand for its services.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 0.96%, reflecting investor disappointment and concerns about future growth.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on new client acquisitions or partnerships.
2Updates on ongoing clinical trials and their potential impact on revenue.
3Insights into market trends affecting the life sciences sector.
4Management's outlook on future revenue growth and operational efficiency.
5Details on cost management strategies and their effectiveness.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance this quarter.

$2.43

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In the last quarter, ICON reported an EPS of $2.52, slightly above expectations. The stock reacted positively, gaining 4.04% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings this quarter, with a consensus EPS of $2.43 and revenue of $2.0B. The company has a strong track record of beating earnings estimates.

Bull Case

If ICON exceeds the EPS estimate, it could signal strong demand for its services, leading to further stock appreciation. The company has consistently beaten EPS estimates in recent quarters.

Bear Case

If ICON misses its EPS target, it may raise concerns about its growth prospects and market conditions, potentially leading to a decline in stock price.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of the company's profitability and performance this quarter.

Revenue

$2.0B

Revenue figures provide insight into the company's sales performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $2.43?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What insights will management provide on revenue growth and market demand?

Understanding revenue drivers will be crucial for assessing the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate ICON's ability to leverage its recent operational efficiencies, which could lead to better-than-expected earnings.

Supporting Evidence

ICON has consistently beaten EPS estimates, suggesting a trend of strong performance.

The options market is pricing a modest move, indicating that many investors may not be anticipating a significant earnings surprise.

Key Risk

If ICON's revenue growth exceeds $2.1B, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether ICON can maintain its growth amid industry challenges.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.29 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a relatively modest move around the earnings report, suggesting uncertainty about the outcome.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests the stock could rise by around 1.22%, confirming strong demand for its services.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 0.96%, reflecting investor disappointment and concerns about future growth.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on new client acquisitions or partnerships.
2Updates on ongoing clinical trials and their potential impact on revenue.
3Insights into market trends affecting the life sciences sector.
4Management's outlook on future revenue growth and operational efficiency.
5Details on cost management strategies and their effectiveness.